TITLE

Other News To Note

PUB. DATE
November 2010
SOURCE
BioWorld Today;11/4/2010, Vol. 21 Issue 214, p4
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
This section offers news briefs related to the pharmaceutical industry as of November 4, 2010. Adventrx Pharmaceuticals Inc. plans to file for a regulatory approval to the U.S. Food and Drug Administration for ANX-530 (vinorelbine injectable emulsion) or Exelbine. Biogen Idec Inc. will implement measures to save 300 million U.S. dollars in annual costs, such as focusing on neurological diseases. Hangzhou Tigermed Consulting Co. Ltd was held as the contract research organization by D-Pharm Ltd. and Wanbang Biopharmaceuticals.
ACCESSION #
55008833

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics